H7N9 and Influenza A RNA Detection Qualitative Test sale cost 1770 AED
Mesoridazine Test sale cost 1900 AED Mesoridazine Test Cost 2,110 د.إ Original price was: 2,110 د.إ.1,900 د.إCurrent price is: 1,900 د.إ.
Alpha Thalassemia Mutation Screening 3 Common Mutation Test sale cost 1600 AED Alpha Thalassemia Mutation Screening 3 Common Mutation Test Cost 2,000 د.إ Original price was: 2,000 د.إ.1,600 د.إCurrent price is: 1,600 د.إ.
Sale!

H7N9 and Influenza A RNA Detection Qualitative Test Cost

Original price was: 2,080 د.إ.Current price is: 1,770 د.إ.

-15%

The “H7N9 and Influenza A RNA Detection Qualitative Test” is a specialized diagnostic tool designed to identify the presence of RNA from the H7N9 virus and other Influenza A viruses in a patient’s sample. This test is crucial for the early detection and management of infections caused by these viruses, which can lead to severe respiratory illnesses and, in some cases, can be fatal. The H7N9 virus, a subtype of Influenza A, has been a particular concern due to its potential to cause pandemics.

This qualitative test employs advanced molecular techniques to accurately detect the RNA of these viruses, offering a high level of sensitivity and specificity. It is an essential tool for epidemiological surveillance and for guiding public health responses during influenza outbreaks.

The test is available at DNA Labs UAE, a leading laboratory known for its state-of-the-art facilities and commitment to providing accurate and reliable diagnostic services. The cost of the test is set at 1770 AED, reflecting the sophisticated technology and expertise required to perform it. By offering this test, DNA Labs UAE plays a vital role in the early detection of H7N9 and Influenza A infections, contributing to the timely treatment and prevention of the spread of these viruses.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

H7N9 and Influenza A RNA Detection Qualitative Test

Test Name: H7N9 and Influenza A RNA Detection Qualitative Test

Components: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.

Price: 1770.0 AED

Sample Condition: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.

Report Delivery: 4th Working Day Email: 48 hours. On phone: 36 hours

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Need to sign Consent document and bring any clinical history of patient for H7N9 & Influenza A (RNA Detection) Qualitative Test

Test Details

The H7N9 & Influenza A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of H7N9 and Influenza A viruses in a patient’s respiratory samples. It is a molecular test that utilizes the reverse transcription-polymerase chain reaction (RT-PCR) technique to amplify and detect specific RNA sequences of the viruses.

The test involves collecting a respiratory sample, such as a nasal or throat swab, from the patient. The sample is then processed in the laboratory, where the RNA is extracted and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR with specific primers targeting the H7N9 and Influenza A RNA sequences.

If the H7N9 or Influenza A viruses are present in the sample, the PCR amplification will generate a positive result, indicating the presence of the viruses. The test can differentiate between H7N9 and other subtypes of Influenza A viruses.

The H7N9 & Influenza A (RNA Detection) Qualitative Test is highly sensitive and specific, providing rapid and accurate results. It is primarily used in outbreak investigations, surveillance programs, and clinical settings to diagnose and monitor H7N9 and Influenza A infections. Early detection of these viruses is crucial for timely treatment and containment of outbreaks.

Test Name H7N9 and Influenza A RNA Detection Qualitative Test
Components
Price 1770.0 AED
Sample Condition Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.
Report Delivery 4th Working Day Email : 48 hours.On phone : 36 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forH7N9 & Influenza A (RNA Detection) QualitativeTest
Test Details

The H7N9 & Influenza A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of H7N9 and Influenza A viruses in a patient’s respiratory samples. It is a molecular test that utilizes the reverse transcription-polymerase chain reaction (RT-PCR) technique to amplify and detect specific RNA sequences of the viruses.

The test involves collecting a respiratory sample, such as a nasal or throat swab, from the patient. The sample is then processed in the laboratory, where the RNA is extracted and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR with specific primers targeting the H7N9 and Influenza A RNA sequences.

If the H7N9 or Influenza A viruses are present in the sample, the PCR amplification will generate a positive result, indicating the presence of the viruses. The test can differentiate between H7N9 and other subtypes of Influenza A viruses.

The H7N9 & Influenza A (RNA Detection) Qualitative Test is highly sensitive and specific, providing rapid and accurate results. It is primarily used in outbreak investigations, surveillance programs, and clinical settings to diagnose and monitor H7N9 and Influenza A infections. Early detection of these viruses is crucial for timely treatment and containment of outbreaks.

SKU: TEST-5111